# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013163
Filing Date
2022-05-13
Accepted
2022-05-13 06:45:43
Documents
94
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 768254
2 |  | ex31-1.htm | EX-31.1 | 10933
3 |  | ex32-1.htm | EX-32.1 | 7436
| Complete submission text file | 0001493152-22-013163.txt |  | 4769027

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bfri-20220331.xsd | EX-101.SCH | 52723
5 | INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bfri-20220331_cal.xml | EX-101.CAL | 68663
6 | INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bfri-20220331_def.xml | EX-101.DEF | 186098
7 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bfri-20220331_lab.xml | EX-101.LAB | 363387
8 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bfri-20220331_pre.xml | EX-101.PRE | 292510
88 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 581350

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 22920183
SIC: 2834 Pharmaceutical Preparations